These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30123939)

  • 21. [Medical management of transgender children and adolescents].
    Castilla-Peón MF
    Bol Med Hosp Infant Mex; 2018; 75(1):7-14. PubMed ID: 29652872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent.
    Milrod C
    J Sex Med; 2014 Feb; 11(2):338-46. PubMed ID: 24238576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual Treatment Progress Predicts Satisfaction With Transition-Related Care for Youth With Gender Dysphoria: A Prospective Clinical Cohort Study.
    Nieder TO; Mayer TK; Hinz S; Fahrenkrug S; Herrmann L; Becker-Hebly I
    J Sex Med; 2021 Mar; 18(3):632-645. PubMed ID: 33642235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fertility Preservation for Transgender Adolescents.
    Chen D; Simons L; Johnson EK; Lockart BA; Finlayson C
    J Adolesc Health; 2017 Jul; 61(1):120-123. PubMed ID: 28363716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature.
    Rew L; Young CC; Monge M; Bogucka R
    Child Adolesc Ment Health; 2021 Feb; 26(1):3-14. PubMed ID: 33320999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urological and Gynaecological Considerations for the Use of Gonadotropin-releasing Hormone Analogues in Transgender and Nonbinary Adolescents: A Narrative Review.
    Lee WG; Butler G; Carmichael P; Rashid T; Yasmin E; Morley R; Barrett J; Christopher N; Sangster P
    Eur Urol Focus; 2023 Jan; 9(1):35-41. PubMed ID: 36396559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender-Affirming Pharmacological Interventions for Youth With Gender Dysphoria: When Treatment Guidelines Are Not Enough.
    Nahata L; Chelvakumar G; Leibowitz S
    Ann Pharmacother; 2017 Nov; 51(11):1023-1032. PubMed ID: 28660776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone Therapy in Children and Adolescents.
    Abramowitz J
    Endocrinol Metab Clin North Am; 2019 Jun; 48(2):331-339. PubMed ID: 31027543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting the effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria.
    Biggs M
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):937-939. PubMed ID: 33894110
    [No Abstract]   [Full Text] [Related]  

  • 31. Adolescents with gender dysphoria.
    Cohen-Kettenis PT; Klink D
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):485-95. PubMed ID: 26051304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mental Health Concerns and Insurance Denials Among Transgender Adolescents.
    Nahata L; Quinn GP; Caltabellotta NM; Tishelman AC
    LGBT Health; 2017 Jun; 4(3):188-193. PubMed ID: 28402749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Mental Health of Transgender Youth: Advances in Understanding.
    Connolly MD; Zervos MJ; Barone CJ; Johnson CC; Joseph CL
    J Adolesc Health; 2016 Nov; 59(5):489-495. PubMed ID: 27544457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Youth and Caregiver Perspectives on Barriers to Gender-Affirming Health Care for Transgender Youth.
    Gridley SJ; Crouch JM; Evans Y; Eng W; Antoon E; Lyapustina M; Schimmel-Bristow A; Woodward J; Dundon K; Schaff R; McCarty C; Ahrens K; Breland DJ
    J Adolesc Health; 2016 Sep; 59(3):254-261. PubMed ID: 27235374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D; T'Sjoen G; Ravn P; Andersen MS
    Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis.
    Abel BS
    Hastings Cent Rep; 2014 Sep; 44 Suppl 4():S23-7. PubMed ID: 25231782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L; Segev-Becker A; Israeli G; Elkon-Tamir E; Oren A
    LGBT Health; 2020; 7(6):340-344. PubMed ID: 32735503
    [No Abstract]   [Full Text] [Related]  

  • 38. What the Primary Care Pediatrician Needs to Know About Gender Incongruence and Gender Dysphoria in Children and Adolescents.
    de Vries AL; Klink D; Cohen-Kettenis PT
    Pediatr Clin North Am; 2016 Dec; 63(6):1121-1135. PubMed ID: 27865337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents.
    Neyman A; Fuqua JS; Eugster EA
    J Adolesc Health; 2019 Apr; 64(4):544-546. PubMed ID: 30612811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Gender Dysphoria, Interpersonal Minority Stress, and Mental Health Among Transgender Youth After One Year of Hormone Therapy.
    Chelliah P; Lau M; Kuper LE
    J Adolesc Health; 2024 Jun; 74(6):1106-1111. PubMed ID: 38340124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.